Literature DB >> 8898965

Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation.

B F Gibbs1, H Haas, F H Falcone, C Albrecht, I B Vollrath, T Noll, H H Wolff, U Amon.   

Abstract

Recent studies have shown that human basophils, like mast cells, generate interleukin (IL)-4 following immunological activation and may thus participate in late-phase allergic and inflammatory processes. Here, we report the capacity of human basophils to release IL-13 within 24 h following stimulation with anti-IgE. Additionally, in 14 out of 31 experiments, we observed that basophils rapidly release performed IL-4 within 5-10 min, as well as newly generated IL-4, which was released 4 h following stimulation of the cells with anti-IgE. In contrast to the biphasic release of IL-4 from the cells, no preformed IL-13 was detected at earlier times (5-30 min). Preformed IL-4 and IL-4 and IL-13 generated de novo were also released after stimulation of the cells with IL-3; an enhanced production of these cytokines was observed using a combination of IL-3 and anti-IgE. We conclude from these data that, by releasing performed IL-4 and IL-4 and IL-13 generated de novo, human basophils may be centrally involved in the orchestration of allergic inflammation by providing a trigger to IL-4-mediated T helper 2 lymphocyte activation, B cell IgE switching, and increased vascular adhesion molecule expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898965     DOI: 10.1002/eji.1830261033

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

Review 1.  New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation.

Authors:  Mark C Siracusa; Michael R Comeau; David Artis
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  Basophils and type 2 immunity.

Authors:  Booki Min; William E Paul
Journal:  Curr Opin Hematol       Date:  2008-01       Impact factor: 3.284

Review 3.  Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation.

Authors:  Zhou Zhu; Sun Young Oh; You Sook Cho; Li Zhang; Yoon-Keun Kim; Tao Zheng
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 4.  Basophil-derived IL-4 plays versatile roles in immunity.

Authors:  Yoshinori Yamanishi; Hajime Karasuyama
Journal:  Semin Immunopathol       Date:  2016-05-10       Impact factor: 9.623

Review 5.  Functional heterogeneity in the basophil cell lineage.

Authors:  Mark C Siracusa; Elia D Tait Wojno; David Artis
Journal:  Adv Immunol       Date:  2012       Impact factor: 3.543

Review 6.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

7.  Modulation of exaggerated-IgE allergic responses by gene transfer-mediated antagonism of IL-13 and IL-17e.

Authors:  Christian Mueller; Allison Keeler; Sofia Braag; Timothy Menz; Qiushi Tang; Terence R Flotte
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

8.  Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils.

Authors:  Nahid Eskandari; Thulani Wickramasinghe; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

9.  Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.

Authors:  Janet M Oliver; Christy A Tarleton; Laura Gilmartin; Tereassa Archibeque; Clifford R Qualls; Lorena Diehl; Bridget S Wilson; Mark Schuyler
Journal:  Int Arch Allergy Immunol       Date:  2009-10-22       Impact factor: 2.749

Review 10.  Interleukin-13: prospects for new treatments.

Authors:  C E Brightling; S Saha; F Hollins
Journal:  Clin Exp Allergy       Date:  2009-10-30       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.